Bank Hapoalim BM Reduces Holdings in VanEck Pharmaceutical ETF (NASDAQ:PPH)

Bank Hapoalim BM decreased its holdings in shares of VanEck Pharmaceutical ETF (NASDAQ:PPH) by 91.4% during the fourth quarter, according to its most recent disclosure with the SEC. The fund owned 4,143 shares of the company’s stock after selling 43,797 shares during the period. Bank Hapoalim BM owned approximately 0.06% of VanEck Pharmaceutical ETF worth $357,000 at the end of the most recent quarter.

A number of other large investors have also modified their holdings of the business. Townsquare Capital LLC boosted its position in VanEck Pharmaceutical ETF by 3.8% in the third quarter. Townsquare Capital LLC now owns 3,519 shares of the company’s stock valued at $334,000 after buying an additional 130 shares during the last quarter. FMR LLC boosted its position in VanEck Pharmaceutical ETF by 12.5% in the third quarter. FMR LLC now owns 1,905 shares of the company’s stock valued at $181,000 after buying an additional 212 shares during the last quarter. Assetmark Inc. lifted its holdings in VanEck Pharmaceutical ETF by 5.8% in the third quarter. Assetmark Inc. now owns 6,491 shares of the company’s stock valued at $617,000 after acquiring an additional 354 shares during the period. Harbour Investments Inc. lifted its holdings in VanEck Pharmaceutical ETF by 16.6% in the third quarter. Harbour Investments Inc. now owns 3,425 shares of the company’s stock valued at $325,000 after acquiring an additional 488 shares during the period. Finally, Stifel Financial Corp lifted its holdings in VanEck Pharmaceutical ETF by 13.4% in the third quarter. Stifel Financial Corp now owns 7,810 shares of the company’s stock valued at $742,000 after acquiring an additional 924 shares during the period.

VanEck Pharmaceutical ETF Trading Down 0.5 %

Shares of NASDAQ:PPH opened at $88.47 on Wednesday. VanEck Pharmaceutical ETF has a 12-month low of $84.48 and a 12-month high of $99.51. The company has a market capitalization of $547.63 million, a PE ratio of 21.04 and a beta of 0.72. The business has a 50 day moving average of $87.78 and a two-hundred day moving average of $91.77.

VanEck Pharmaceutical ETF Increases Dividend

The business also recently declared a dividend, which was paid on Monday, December 30th. Shareholders of record on Friday, December 27th were issued a $0.411 dividend. The ex-dividend date was Friday, December 27th. This is an increase from VanEck Pharmaceutical ETF’s previous dividend of $0.36.

About VanEck Pharmaceutical ETF

The VanEck Pharmaceutical ETF (PPH) is an exchange-traded fund that is based on the MVIS US Listed Pharmaceutical 25 index, a market-cap-weighted index of 25 of the largest global pharmaceutical firms. PPH was launched on Feb 1, 2000 and is managed by VanEck.